Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
January 21, 2025 16:10 ET
|
Sanara MedTech Inc.
OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara’s existing call points and...
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments
January 21, 2025 16:08 ET
|
Sanara MedTech Inc.
Elizabeth Taylor Appointed Chief Financial Officer; Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara...
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
January 21, 2025 16:05 ET
|
Sanara MedTech Inc.
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) --...
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
January 10, 2025 08:30 ET
|
NeuroOne Medical Technologies Corporation
First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue Management to Host Virtual Investor...
NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024
January 06, 2025 08:30 ET
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
January 03, 2025 08:30 ET
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
December 17, 2024 08:30 ET
|
NeuroOne Medical Technologies Corp
Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly EDEN PRAIRIE, Minn., Dec. 17, 2024 ...
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
November 14, 2024 16:30 ET
|
GlucoTrack, Inc.
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for...
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
November 13, 2024 09:00 ET
|
GlucoTrack, Inc.
Rutherford, NJ., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for...
Sanara MedTech Inc. Reports Third Quarter 2024 Results
November 12, 2024 16:15 ET
|
Sanara MedTech Inc.
FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical...